Scisparc Ltd
NASDAQ:SPRC

Watchlist Manager
Scisparc Ltd Logo
Scisparc Ltd
NASDAQ:SPRC
Watchlist
Price: 0.99 USD -1.98% Market Closed
Market Cap: $3.2m

Net Margin

-2 023.9%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 023.9%
=
Net Income
$-9.3m
/
Revenue
$461k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 023.9%
=
Net Income
$-9.3m
/
Revenue
$461k

Peer Comparison

Country Company Market Cap Net
Margin
IL
Scisparc Ltd
NASDAQ:SPRC
3.2m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Lower than 96% of companies in Israel
Percentile
4th
Based on 749 companies
4th percentile
-2 023.9%
Low
-85 210% — -8.6%
Typical Range
-8.6% — 7.2%
High
7.2% — 23 652.1%
Distribution Statistics
Israel
Min -85 210%
30th Percentile -8.6%
Median 1.8%
70th Percentile 7.2%
Max 23 652.1%

Scisparc Ltd
Glance View

Market Cap
3.2m USD
Industry
Biotechnology

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

SPRC Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2 023.9%
=
Net Income
$-9.3m
/
Revenue
$461k
What is Scisparc Ltd's current Net Margin?

The current Net Margin for Scisparc Ltd is -2 023.9%, which is in line with its 3-year median of -2 023.9%.

How has Net Margin changed over time?

Over the last 0 months, Scisparc Ltd’s Net Margin has decreased from -2 023.9% to -2 023.9%. During this period, it reached a low of -2 023.9% on Jun 30, 2025 and a high of -2 023.9% on Jun 30, 2025.

Back to Top